REFERENCES
- Czaja AJ. Autoimmune liver disease. Curr Opin Gastroenterol. 2009; 25: 215–222.
- Moreira RK, Revetta F, Koehler E, Washington MK. Diagnostic utility of IgG and IgM immunohistochemistry in autoimmune liver disease. World J Gastroenterol. 2010; 16: 453–457.
- Talwalkar JA, Lindor KD. Primary biliary cirrhosis. Lancet. 2003; 362: 53–61.
- Yoshida EM, Riley M, Arbour LT. Autoimmune liver disease and the Canadian First Nations Aboriginal Communities of British Columbia’s Pacific Northwest. World J Gastroenterol. 2006; 12: 3625–3627.
- Patel SJ, Lundy DC. Ocular manifestations of autoimmune disease. Am Fam Physician. 2002; 66: 991–998.
- Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999; 31: 929–938.
- Peters MG. Animal models of autoimmune liver disease. Immunol Cell Biol. 2002; 80: 113–116.
- Strassburg CP. Autoimmune hepatitis. Best Pract Res Clin Gastroenterol. 2010; 24: 667–682.
- Teufel A, Weinmann A, Kahaly GJ, et al. Concurrent autoimmune diseases in patients with autoimmune hepatitis. J Clin Gastroenterol. 2010; 44: 208–213.
- McFarlane IG. Autoimmune liver disease. Scand J Clin Lab Invest. 2001; 61: 53–60.
- Strassburg CP. Autoimmune hepatitis. Best Pract Res Clin Gastroenterol. 2010; 24: 667–682.
- Zolfino T, Heneghan MA, Norris S, Harrison PM, Portmann BC, McFarlane IG. Characteristics of autoimmune hepatitis in patients who are not of European Caucasoid ethnic origin. Gut. 2002; 50: 713–717.
- Spraul CW, Lang GE, Lang GK. Retinal pigment epithelial changes associated with systemic corticosteroid treatment: report of cases and review of the literature. Ophthalmologica. 1998; 212: 142–148.
- Lim LL, Scarborough JD, Thorne JE, et al. Uveitis in patients with autoimmune hepatitis. Am J Ophthalmol. 2009; 147: 332–338.
- Kamal A, Bhan A, Murray PI. Uveitis with autoimmune hepatic disorders. Ocul Immunol Inflamm. 2001; 9: 267–272.
- Karp JK, Akpek EK, Anders RA. Autoimmune hepatitis in patients with primary Sjögren’s syndrome: a series of two-hundred and two patients. Int J Clin Exp Pathol. 2010; 3: 582–586.
- Webb J, Whaley K, MacSween RN, Nuki G, Dick WC, Buchanan WW. Liver disease in rheumatoid arthritis and Sjogren’s syndrome: prospective study using biochemical and serological markers of hepatic dysfunction. Ann Rheum Dis. 1975; 34: 70–81.
- Tsianos EV, Hoofnagle JH, Fox PC, et al. Sjogren’s syndrome in patients with primary biliary cirrhosis. Hepatology. 1990; 11: 730–734.
- Skopouli FN, Barbatis C, Moutsopoulos HM. Liver involvement in primary Sjogren’s syndrome. Br J Rheumatol. 1994; 33: 745–748.
- Lindgren S, Manthorpe R, Eriksson S. Autoimmune liver disease in patients with primary Sjogren’s syndrome. J Hepatol. 1994; 20: 354–358.
- Montano-Loza AJ, Crispin-Acuna JC, Remes-Troche JM, Uribe M. Abnormal hepatic biochemistries and clinical liver disease in patients with primary Sjogren’s syndrome. Ann Hepatol. 2007; 6:150–155.
- Matsumoto T, Morizane T, Aoki Y, et al. Autoimmune hepatitis in primary Sjogren’s syndrome: pathological study of the livers and labial salivary glands in 17 patients with primary Sjogren’s syndrome. Pathol Int. 2005; 55: 70–76.